If approved, donidalorsen would be a first-in-class RNA-targeted medicine for hereditary angioedema. The agency’s goal date ...

Barclays analyst Balaji Prasad maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $242.00. The ...

The US regulator is also reviewing a supplemental new drug application for VTAMA cream as a potential treatment for atopic dermatitis. Credit: iced.espresso ...

The acquisition expands Organon’s dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. BASEL, Switzerland and LONDON and NEW YORK, Oct. 28, 2024 ...

BASEL, Switzerland and LONDON and NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives ...

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials ...

The acquisition expands Organon’s dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare ...

Traditional Chinese Medicine (TCM) is a holistic approach to treating a person’s mental and physical health problems. It developed thousands of years ago, and its core practices have changed little ...

A new Review article series, “AI in Medicine,” explores the role of AI technology in clinical medicine and digital health, and examines the promise and pitfalls of its application across the ...

Investors in Organon & Co. OGN need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $2.50 Call had some of the highest implied ...